Biotech

dollar sign pipeline

Biotech

Ethyreal Bio raises $101M, joining biotechs gunning for Tepezza

Backed by investors including Atlas Venture and Medicxi Ventures, Ethyreal has quietly advanced an anti-TSHR antibody to the cusp of the clinic.

Nick Paul Taylor Jun 10, 2026 9:35am

fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: Ethyreal, City & more

Jun 10, 2026 9:30am

How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

glue scissors art supplies

Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B

Jun 10, 2026 8:21am

Managing complexity across biopharma modalities

Managing complexity across biopharma modalities

Brought to you by SK Pharmteco

calendar

Parabilis’ upsized $670M IPO breaks new record for biotechs

Jun 10, 2026 4:36am